Up-regulation of alternate co-stimulatory molecules on proinflammatory CD28null T cells in bronchiolitis obliterans syndrome

Clinical and Experimental Immunology

Volumn 173, Issue 1, 2013, Pages 150-160

  Hodge, G ^a,b   Hodge, S ^a,b   Ahern, J ^a,b   Holmes Liew, C L ^a,b,c   Reynolds, P N ^a,b   Holmes, M ^a,b,c  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c South Australian Lung Transplant Service   (Australia)

Author keywords

BOS; CD28null; Lung transplant; Proinflammatory T cells

Indexed keywords

CD134 ANTIGEN; CD137 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FLUORESCEIN ISOTHIOCYANATE; GAMMA INTERFERON; GRANZYME B; METHYLPREDNISOLONE; PHYCOERYTHRIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DOWN REGULATION; ERYTHROCYTE; FEMALE; FIBROSING ALVEOLITIS; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN CELL; LEUKOCYTE DIFFERENTIAL COUNT; LUNG EMPHYSEMA; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; UPREGULATION;

ADULT; ANTIGENS, CD137; ANTIGENS, CD28; BRONCHIOLITIS OBLITERANS; CASE-CONTROL STUDIES; CD40 LIGAND; COSTIMULATORY AND INHIBITORY T-CELL RECEPTORS; CTLA-4 ANTIGEN; CYCLOSPORINE; FEMALE; GRANZYMES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; LUNG TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PERFORIN; POSTOPERATIVE COMPLICATIONS; RECEPTORS, OX40; T-LYMPHOCYTE SUBSETS; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84878788742     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12081     Document Type: Article

References (22)

1. Lama R, Santos F, Alvarez A etal. Analysis of lung transplant recipients surviving beyond 5 years. Transplant Proc 2005; 37:1523-1525.
2. Hodge S, Hodge G, Ahern J etal. Increased levels of T cell granzyme B in BOS are not suppressed adequately by current immunosuppressive regimens. Clin Exp Immunol 2009; 158:230-236.
3. Hodge G, Hodge S, Chambers D, Reynolds PN, Holmes M. Bronchiolitis obliterans syndrome is associated with absence of suppression of peripheral blood Th1 pro-inflammatory cytokines. Transplantation 2009; 88:211-218.
4. Corris PA, Kirby JA. A role for cytokine measurement in therapeutic monitoring of immunosuppressive drugs following lung transplantation. Clin Exp Immunol 2005; 139:176-179.
5. Hodge G, Hodge S, Li-Liew C, Chambers D, Reynolds PN, Holmes M. Lymphocytic bronchiolitis is associated with inadequate suppression of blood T-cell granzyme B, IFNγ and TNFα. Transplantation 2010; 89:1283-1289.
6. Guinan EC, Gribben JG, Bousiottis V, Freeman GJ, Nadler LM. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumour immunity. Blood 1994; 84:3261-3282.
7. Strioga M, Pasukoniene V, Characiejus D. CD8+CD28- and CD8+CD57+ T cells and their role in health and disease. Immunology 2011; 134:17-32.
8. Hodge G, Mukaro V, Reynolds PN, Hodge S. Role of increased CD8/CD28(null) T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease. Clin Exp Immunol 2011; 166:94-102.
9. + subpopulation. Clin Immunol 2000; 96:230-235.
10. Hodge G, Hodge S, Liew-Holmes CL, Reynolds PN, Holmes M. Increased natural killer T-like cells are a major source of pro-inflammatory cytokines and granzymes in lung transplant recipients. Respirology 2011; 17:155-163.
11. Stewart S, Fishbein MC, Snell GI etal. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Transplant 2007; 26:1229-1242.
12. Sato M, Waddell TK, Wagnetz U etal. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 2011; 30:735-742.
13. Hodge G, Hodge S, Reynolds P, Holmes M. Intracellular cytokines in blood T cells in lung transplant patients - a more relevant indicator of immunosuppression than drug levels. Clin Exp Immunol 2005; 139:159-164.
14. Hodge G, Han P. Effect of Factor VIII on antigen presenting cell (APC)/T cell interactions in vitro: relevance to inhibitor formation and tolerance induction. Br J Haematol 2000; 109:195-200.
15. Hodge G, Mukaro V, Reynolds PN, Hodge S. Role of increased CD8/CD28(null) T cells in alternative co-stimulatory molecules in chronic obstructive pulmonary disease. Clin Exp Immunol 2011; 166:94-102.
16. Vallejo AN. CD28 extinction in the human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005; 205:158-169.
17. Struder S, George P, Zhu X etal. CD28 down-regulation of CD4 T cells is a marker for graft dysfunction in lung transplant recipients. Am J Respir Crit Care Med 2008; 178:765-773.
18. Lehman C, Wilkening A, Lieber N etal. Lymphocytes in the bronchiolar space reenter the lung tissue by means of the alveolar epithelium, migrate to regional lymph nodes, and subsequently rejoin the systemic immune system. Anat Rec 2001; 264:229-236.
19. LePriol Y, Puthier D, Lecureuil C etal. High cytotoxic and migratory potencies of senescent CD8+CD57+ cells in HIV-infected and uninfected individuals. J Immunol 2006; 177:5145-5155.
20. Sada-Ovalle I, Torre-Bouscoulet L, Valdez-Vaquez R, Martinez-Cairo S, Zenito E, Lascurain R. Characterisation of a cytotoxic CD57+ T cell subset from patients with pulmonary tuberculosis. Clin Immunol 2006; 121:314-323.
21. Fasth AE, Dastmalchi M, Rahbar A etal. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. J Immunol 2009; 183:4792-4799.
22. - T cells in induced sputum from asthmatic patients. Mediators Inflamm 2005; 205:160-166.